mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.2 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |